IQVIA and Veeva expand partnership to speed clinical trials
Clinical research firm IQVIA and cloud provider Veeva Systems have widened their existing partnership. The upgrade adds Veeva trial management systems as standard applications.
By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .
This story is no longer being updated. It reflects reporting up to .
What happened
IQVIA, a clinical research company, and Veeva Systems, a cloud system provider, have expanded their existing partnership. The goal is to further increase the speed and efficiency of clinical trials. The upgraded arrangement brings in Veeva trial management systems such as Veeva CTMS, eTMF, Study Startup and Site Connect as enterprise standard applications.
Why it matters
The expanded partnership is aimed at making clinical trials faster and more efficient.
Coverage
- IQVIA, Veeva expand on existing partnership for speedier clinical trials (fiercebiotech.com)
- How Could IQVIA Holdings (NYSE:IQV) Change Clinical Trial Design? (kalkinemedia.com)
More from Health
- Hackensack Meridian Health and Hunterdon Health agree to merge
- Roche signs $15 billion antibody-drug conjugate deal with Hansoh
- Putin's daughter predicts aging breakthroughs within 10 to 20 years
- Cardiologists urged to prescribe exercise for heart patients
- Pennsylvania measles outbreak tops 1,200 as CDC sends investigator
- AstraZeneca enlists Oracle to apply AI in drug trials